Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.23% | -1,708.57% | 64.60% | 15.27% | 11.03% |
| Total Depreciation and Amortization | -1.46% | 7.47% | 7.61% | 6.98% | 3.40% |
| Total Amortization of Deferred Charges | 117.98% | 98.17% | 76.93% | 111.67% | 88.25% |
| Total Other Non-Cash Items | -91.03% | 131.63% | -85.12% | 525.97% | 9.44% |
| Change in Net Operating Assets | 1,835.00% | -3.63% | -1,373.98% | -93.07% | -94.50% |
| Cash from Operations | 34.65% | 62.55% | 29.92% | 36.77% | 18.80% |
| Capital Expenditure | 100.00% | 100.79% | 98.71% | -4,175.00% | -1.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 100.00% | 101.69% | -100.22% | -106.25% | -101.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -137.38% | 82.13% | -155.72% | -2.60% | 164.46% |
| Issuance of Common Stock | -- | -- | -32.50% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 96.78% | -- | -- |
| Cash from Financing | -647.66% | 1,912.00% | -85.76% | 14,955.84% | 184.92% |
| Foreign Exchange rate Adjustments | 498.87% | -302.63% | 757.69% | 97.71% | -7.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.76% | 221.74% | -4,676.19% | 144.90% | -96.57% |
